7611 - 7620 of 8618 Results
Title
Year
- Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease2021RESTRICTEDTitle: Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1964End Page: 1967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28630Citation Count: 4
-
OPENTitle: Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 7Start Page: 1350End Page: 1355Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29424Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29424Citation Count: 10
- Assessing Visuospatial Skills in Parkinson's: Comparison of Neuropsychological Assessment Battery Visual Discrimination to the Judgment of Line Orientation2016OPENTitle: Assessing Visuospatial Skills in Parkinson's: Comparison of Neuropsychological Assessment Battery Visual Discrimination to the Judgment of Line OrientationJournal Name: Archives of Clinical NeuropsychologyPublisher: Oxford University Press (OUP)Vol: 32Issue #: 1Start Page: 123End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/arclin/acw102Best OA location URL: https://academic.oup.com/acn/article-pdf/32/1/123/9951631/acw102.pdfCitation Count: 4
-
OPENTitle: MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSPJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 46Issue #:Start Page: 47End Page: 55Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.020Citation Count: 50
-
RESTRICTEDTitle: Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cellsJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 27Start Page: 12858End Page: 12870Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c9nr01277jCitation Count: 53
- New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's disease2014OPENTitle: New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's diseaseJournal Name: Neurogastroenterology & MotilityPublisher: WileyVol: 26Issue #: 12Start Page: 1771End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nmo.12459Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4457321Citation Count: 50
- O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH2018RESTRICTEDTitle: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACHJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 7S_Part_11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691Citation Count: 0
- N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine2024OPENTitle: N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholineJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.97228Best OA location URL: https://doi.org/10.7554/elife.97228Citation Count: 2
- An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural Networks2024RESTRICTEDTitle: An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural NetworksJournal Name: Digital Signal ProcessingPublisher: Elsevier BVVol: 147Issue #:Start Page: 104407End Page: 104407Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.dsp.2024.104407Citation Count: 9
- l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease2019OPENTitle: l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 150Issue #: 1Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14676Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14676Citation Count: 31